Value added tax (VAT) is no longer applied to at least 21 medications that treat cancer, diabetes, hypertension, kidney disease, mental illness, and tuberculosis (TB), according to a Wednesday, January 31 announcement from the Bureau of Internal Revenue (BIR). After receiving a letter from the Food and Drug Administration (FDA)